YG-1 Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

YG-1 has a total shareholder equity of ₩392.4B and total debt of ₩551.7B, which brings its debt-to-equity ratio to 140.6%. Its total assets and total liabilities are ₩1,045.5B and ₩653.1B respectively. YG-1's EBIT is ₩49.3B making its interest coverage ratio 1.7. It has cash and short-term investments of ₩54.1B.

Anahtar bilgiler

140.6%

Borç/özkaynak oranı

₩551.68b

Borç

Faiz karşılama oranı1.7x
Nakit₩54.09b
Eşitlik₩392.37b
Toplam yükümlülükler₩653.11b
Toplam varlıklar₩1.05t

Son finansal sağlık güncellemeleri

Recent updates

YG-1's (KOSDAQ:019210) Anemic Earnings Might Be Worse Than You Think

Mar 27
YG-1's (KOSDAQ:019210) Anemic Earnings Might Be Worse Than You Think

YG-1 (KOSDAQ:019210) Has Debt But No Earnings; Should You Worry?

Mar 30
YG-1 (KOSDAQ:019210) Has Debt But No Earnings; Should You Worry?

Should YG-1 Co., Ltd. (KOSDAQ:019210) Be Part Of Your Income Portfolio?

Mar 04
Should YG-1 Co., Ltd. (KOSDAQ:019210) Be Part Of Your Income Portfolio?

A Look At YG-1's (KOSDAQ:019210) Share Price Returns

Jan 28
A Look At YG-1's (KOSDAQ:019210) Share Price Returns

Here's Why We're Wary Of Buying YG-1's (KOSDAQ:019210) For Its Upcoming Dividend

Dec 24
Here's Why We're Wary Of Buying YG-1's (KOSDAQ:019210) For Its Upcoming Dividend

Should You Buy YG-1 Co., Ltd. (KOSDAQ:019210) For Its Dividend?

Dec 03
Should You Buy YG-1 Co., Ltd. (KOSDAQ:019210) For Its Dividend?

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: A019210's short term assets (₩551.9B) exceed its short term liabilities (₩502.5B).

Uzun Vadeli Yükümlülükler: A019210's short term assets (₩551.9B) exceed its long term liabilities (₩150.6B).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: A019210's net debt to equity ratio (126.8%) is considered high.

Borcun Azaltılması: A019210's debt to equity ratio has increased from 133.3% to 140.6% over the past 5 years.

Borç Kapsamı: A019210's debt is not well covered by operating cash flow (12.2%).

Faiz Kapsamı: A019210's interest payments on its debt are not well covered by EBIT (1.7x coverage).


Bilanço


Sağlıklı şirketleri keşfedin